Wills Hughes-wilson
Senior Vice President, Chief Patient Access Office
Hospital Management
Swedish Orphan Biovitrum AB
Sweden
Biography
Born 1971. Employed since 2012. Honours graduate in Law from University of Durham in the UK. Previous positions: Vice President Health/Market Access Policy EMEA at Genzyme Corporation, now part of the French Sanofi Group. Executive Director of Emerging Biopharmaceutical Enterprises (EBE), a specialised group of the European Federation of Pharmaceuticals Industries & Associations (EFPIA). Government affairs lead within the European animal health/veterinary medicines industry and Ernst & Young Consulting.
Research Interest
Toxicology & Patient Interactions
